Acenzia

What Acenzia does

Acenzia is a privately held Canadian company that operates a vertically integrated B2B platform combining pharmaceutical-grade nutraceutical contract manufacturing with proprietary biotech research and diagnostic services. Formed in 2015 through the merger of Suntrition (a nutraceutical contract manufacturer founded in 2001) and Biomedcore (a biotechnology diagnostics firm), Acenzia is controlled by founders Grant Bourdeau and Dr. Indrajit Sinha and operates from a corporate office in Vaughan, Ontario and a 36,000-square-foot pharmaceutical GMP manufacturing facility with 20 clean rooms in Oldcastle, Ontario, strategically located near the Windsor-Detroit border. The company is certified by Health Canada, the U.S. FDA, and NSF International (GMP for Sport) and serves major branded nutraceutical, health supplement, OTC, functional food, and oncology-related customers worldwide.

The company's service portfolio is organized into three lines: Build (contract manufacturing covering blending, encapsulation, tableting, coating, powder/functional food manufacturing, liquid/gel filling, and packaging); Innovate (oncology research, in-vivo zebrafish pre-clinical models, CTC/liquid biopsy metastatic potential prediction, and the proprietary NHP 2.0 formulation optimization platform for ingredient biological signatures and drug-to-ingredient interactions); and Develop (product development from concept to commercialization, including formulation analysis, regulatory compliance, and market intelligence). Underlying technology assets include a patented oncology platform granted in multiple jurisdictions, the patented NHP 2.0 platform, a patent-pending buccal oral pouch delivery system, and an owned-branded Acenzia Products line. All engagements are delivered through a concierge white-glove service model that supports projects from concept to fulfillment.

Acenzia generates revenue through quote-based B2B contracts across contract manufacturing (the largest stream), research and pre-clinical services, and product development engagements. Pricing is not publicly disclosed. Go-to-market is enterprise sales-led via direct engagement, with marketing primarily conducted through the company website (acenzia.com), phone, and email. The company reports no institutional investors, funding rounds, or external ownership, and revenue figures have not been publicly disclosed; it is described in company history as a multi-million-dollar organization with approximately 50 employees.

Name

Acenzia

Legal name

Acenzia Inc.

Website

https://acenzia.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Acenzia is a Canadian B2B contract manufacturer and bio-science company combining pharmaceutical-grade nutraceutical production with proprietary oncology diagnostics and formulation platforms, serving major branded health product companies worldwide.

Ownership category

akta.pro rank

Product category

Nutraceutical Contract Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

akta.pro secondary industries

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Contract manufacturing services
• Nutraceutical manufacturing
• Oncology diagnostics research
• Product development services
• Pharmaceutical grade manufacturing

Headquarters

HQ city

Tecumseh

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: End-to-end manufacturing services including ingredient sourcing, manufacturing, packaging/labeling, and distribution for nutraceuticals, functional foods, OTC products, and health supplements
2. Research and Development Services: Pre-clinical research, human clinical trials, advanced formulation research, oncology therapy research, and diagnostic development services
3. Product Development Services: Full product development support from concept to commercialization including formulation, regulatory compliance, market intelligence, and diagnostics development

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

Acenzia is a B2B contract manufacturer and bio-science research company providing end-to-end services from formulation to fulfillment for nutraceuticals, OTC products, health supplements, and functional foods. Operated from a 36,000 sqft pharmaceutical-grade GMP facility with 20 clean rooms, the company combines proprietary manufacturing platforms with patented oncology research capabilities, including a zebrafish-based platform for predicting cancer metastasis, the NHP 2.0 formulation optimization platform, and a patent-pending oral pouch delivery system.

Product overview

Acenzia is an advanced manufacturing and bio-science company offering a vertically integrated platform combining contract manufacturing services with proprietary biotech research and diagnostics capabilities. The company's core offerings include contract manufacturing of nutraceuticals, health supplements, OTC products, and functional foods (tablets, capsules, powders, oral pouches) from a 36,000 sqft pharmaceutical-grade facility with 20 clean rooms; an oncology research and diagnostics platform featuring a patented zebrafish-based technology for predicting cancer metastasis and optimizing therapeutic decisions; the NHP 2.0 proprietary formulation optimization platform; and comprehensive product development services from concept to commercialization. The company operates through distinct but coordinated service lines: Build (contract manufacturing), Innovate (research and diagnostics), and Develop (product development), unified by the Acenzia Concierge white glove service. The company was formed through the merger of Suntrition (nutraceutical manufacturing) and Biomedcore (biotechnology diagnostics).

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing Services End-to-end contract manufacturing services for nutraceuticals, OTC products, health supplements, and functional foods, including formulation, blending, encapsulation, tableting, coating, powder/functional food manufacturing, hand sanitizer manufacturing, and packaging/labeling executed in a 36,000 sqft pharmaceutical-grade GMP facility with 20 clean rooms. Target buyers are major branded companies worldwide.
• Oncology Research and Diagnostics Patented oncology research and diagnostic services using in-vivo zebrafish models to predict cancer metastasis, support therapeutic decisions, and conduct pre-clinical trials. Includes circulating tumor cells (CTC) and liquid biopsy analysis. Target buyers are biotechnology and pharmaceutical companies in oncology and therapeutics development.
• Product Development Services Comprehensive product development services from concept to commercialization, including formulation analysis, complex chemical combinations, regulatory compliance, market intelligence, therapeutics development, and diagnostics development. Serves brand owners and companies requiring start-to-finish project assistance.
• Acenzia Concierge White-glove, personalized concierge service providing dedicated project assistance from concept to commercialization for projects of any size, with a specialized team supporting clients through every stage.
• Acenzia Products (Owned Brand) Company-owned brand line of nutraceutical and health supplement products manufactured in-house at the Acenzia pharmaceutical-grade facility.

Quantifiable outcome

• Rapid therapeutic efficacy testing within days using zebrafish models
• +2 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• SuntritioncoreStrategic or Co-development Partner · 1 January 2015Suntrition, a nutraceutical contract manufacturing company named one of Canada's fastest-growing companies for four years straight, merged with Biomedcore in 2015 to form Acenzia. Suntrition provided manufacturing excellence, unique and proprietary evidence-based natural supplements in tablets, capsules and powder formulations.
• BiomedcorecoreStrategic or Co-development Partner · 1 January 2015Biomedcore, a biotechnology company with proprietary diagnostics and a breakthrough proprietary technology for testing personalized products, merged with Suntrition in 2015 to form Acenzia. This partnership added the science platform enabling advanced research and diagnostics capabilities.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Robinson Pharma: Large-scale nutraceutical and OTC contract manufacturer with GMP-certified facilities producing tablets, capsules, softgels, and liquids. Comparable to Acenzia in regulatory certifications and enterprise brand customer base.
• Charles River Laboratories: Major preclinical CRO offering in-vivo models for drug efficacy and safety testing, including zebrafish-based assays. Directly comparable to Acenzia's oncology zebrafish platform and pre-clinical research service line.
• Best Formulations: US-based nutraceutical and OTC contract manufacturer with GMP-certified facilities offering capsules, tablets, powders, and liquids. Closely comparable to Acenzia in customer mix (branded nutraceutical and supplement companies) and dosage form breadth.
• WuXi AppTec: Global CRO/CDMO providing preclinical research, biologics manufacturing, and small-molecule development. Comparable to Acenzia in offering integrated discovery, preclinical, and manufacturing services to pharma/biotech clients.
• Makers Nutrition: Full-service nutraceutical contract manufacturer offering formulation, manufacturing, packaging, and labeling for supplement brands. Directly comparable to Acenzia in B2B CMO positioning and turnkey service offering.
• Vitakem: Nutraceutical and dietary supplement CDMO with manufacturing, packaging, and regulatory services. Comparable in product formats (capsules, tablets, powders) and target customer segment of supplement brands.

Broad incumbents

• Catalent: Large global CDMO providing softgel, oral, and biologics manufacturing plus clinical and commercial supply. Overlaps with Acenzia's contract manufacturing capabilities but at much greater scale and broader portfolio.
• Eurofins Scientific: Global testing, inspection, and certification group operating in food, pharma, and life sciences. Comparable to Acenzia's analytical, microbiology, and biology lab capabilities, but as part of a much broader testing portfolio.
• Aenova Group: European-headquartered pharma and nutraceutical CDMO with solid, semi-solid, liquid, and sterile manufacturing capabilities. Comparable in pharma-grade manufacturing positioning and B2B service model, but at much larger scale.

Emerging players

• Crown Bioscience: Preclinical oncology CRO specializing in translational platforms and in-vivo models for cancer drug development. Comparable to Acenzia's zebrafish and CTC-based oncology research offering, though more focused on murine and PDX models.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Acenzia